The global Circulating Tumor Cells (CTC) market was valued at US$ 1584.6 million in 2023 and is anticipated to reach US$ 4297.5 million by 2030, witnessing a CAGR of 15.0% during the forecast period 2024-2030.

Circulating Tumor Cells (CTC) Market

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, Qiagen（Adnagen）, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.

This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cells (CTC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cells (CTC).

Report Scope

The Circulating Tumor Cells (CTC) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Circulating Tumor Cells (CTC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Circulating Tumor Cells (CTC) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Circulating Tumor Cells (CTC) Market Report

Report Metric	Details
Report Name	Circulating Tumor Cells (CTC) Market
Accounted market size in 2023	US$ 1584.6 million
Forecasted market size in 2030	US$ 4297.5 million
CAGR	15.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Ex-Vivo Positive Selection In-Vivo Positive Selection Negative Selection Microchips & Single Spiral Micro Channel
Segment by Application	Tumorigenesis Research Emt Biomarkers Development Cancer Stem Cell Research Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AdnaGen, Apocell, Biocep, Canopus Bioscience, Creatv Microtech, Ikonisys, IV Diagnostics, Miltenyi Biotech, Nanostring Technologies, Rarecells Diagnostics, Vitatex
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cells (CTC) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Circulating Tumor Cells (CTC) Market growing?

Ans: The Circulating Tumor Cells (CTC) Market witnessing a CAGR of 15.0% during the forecast period 2024-2030.

What is the Circulating Tumor Cells (CTC) Market size in 2030?

Ans: The Circulating Tumor Cells (CTC) Market size in 2030 will be US$ 4297.5 million.

What is the market share of major companies in Circulating Tumor Cells (CTC) Market?

Ans: Global top five manufacturers hold a share over 30%.

Who are the main players in the Circulating Tumor Cells (CTC) Market report?

Ans: The main players in the Circulating Tumor Cells (CTC) Market are AdnaGen, Apocell, Biocep, Canopus Bioscience, Creatv Microtech, Ikonisys, IV Diagnostics, Miltenyi Biotech, Nanostring Technologies, Rarecells Diagnostics, Vitatex

What are the Application segmentation covered in the Circulating Tumor Cells (CTC) Market report?

Ans: The Applications covered in the Circulating Tumor Cells (CTC) Market report are Tumorigenesis Research, Emt Biomarkers Development, Cancer Stem Cell Research, Others

What are the Type segmentation covered in the Circulating Tumor Cells (CTC) Market report?

Ans: The Types covered in the Circulating Tumor Cells (CTC) Market report are Ex-Vivo Positive Selection, In-Vivo Positive Selection, Negative Selection, Microchips & Single Spiral Micro Channel

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Ex-Vivo Positive Selection

1.2.3 In-Vivo Positive Selection

1.2.4 Negative Selection

1.2.5 Microchips & Single Spiral Micro Channel

1.3 Market by Application

1.3.1 Global Circulating Tumor Cells (CTC) Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Tumorigenesis Research

1.3.3 Emt Biomarkers Development

1.3.4 Cancer Stem Cell Research

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Circulating Tumor Cells (CTC) Market Perspective (2019-2030)

2.2 Circulating Tumor Cells (CTC) Growth Trends by Region

2.2.1 Global Circulating Tumor Cells (CTC) Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Circulating Tumor Cells (CTC) Historic Market Size by Region (2019-2024)

2.2.3 Circulating Tumor Cells (CTC) Forecasted Market Size by Region (2025-2030)

2.3 Circulating Tumor Cells (CTC) Market Dynamics

2.3.1 Circulating Tumor Cells (CTC) Industry Trends

2.3.2 Circulating Tumor Cells (CTC) Market Drivers

2.3.3 Circulating Tumor Cells (CTC) Market Challenges

2.3.4 Circulating Tumor Cells (CTC) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue

3.1.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue (2019-2024)

3.1.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Players (2019-2024)

3.2 Global Circulating Tumor Cells (CTC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Circulating Tumor Cells (CTC) Revenue

3.4 Global Circulating Tumor Cells (CTC) Market Concentration Ratio

3.4.1 Global Circulating Tumor Cells (CTC) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTC) Revenue in 2023

3.5 Circulating Tumor Cells (CTC) Key Players Head office and Area Served

3.6 Key Players Circulating Tumor Cells (CTC) Product Solution and Service

3.7 Date of Enter into Circulating Tumor Cells (CTC) Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Circulating Tumor Cells (CTC) Breakdown Data by Type

4.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Type (2019-2024)

4.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2025-2030)

5 Circulating Tumor Cells (CTC) Breakdown Data by Application

5.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Application (2019-2024)

5.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Circulating Tumor Cells (CTC) Market Size (2019-2030)

6.2 North America Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Circulating Tumor Cells (CTC) Market Size by Country (2019-2024)

6.4 North America Circulating Tumor Cells (CTC) Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Circulating Tumor Cells (CTC) Market Size (2019-2030)

7.2 Europe Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Circulating Tumor Cells (CTC) Market Size by Country (2019-2024)

7.4 Europe Circulating Tumor Cells (CTC) Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size (2019-2030)

8.2 Asia-Pacific Circulating Tumor Cells (CTC) Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2019-2024)

8.4 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Circulating Tumor Cells (CTC) Market Size (2019-2030)

9.2 Latin America Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2019-2024)

9.4 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size (2019-2030)

10.2 Middle East & Africa Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2019-2024)

10.4 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AdnaGen

11.1.1 AdnaGen Company Detail

11.1.2 AdnaGen Business Overview

11.1.3 AdnaGen Circulating Tumor Cells (CTC) Introduction

11.1.4 AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)

11.1.5 AdnaGen Recent Development

11.2 Apocell

11.2.1 Apocell Company Detail

11.2.2 Apocell Business Overview

11.2.3 Apocell Circulating Tumor Cells (CTC) Introduction

11.2.4 Apocell Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)

11.2.5 Apocell Recent Development

11.3 Biocep

11.3.1 Biocep Company Detail

11.3.2 Biocep Business Overview

11.3.3 Biocep Circulating Tumor Cells (CTC) Introduction

11.3.4 Biocep Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)

11.3.5 Biocep Recent Development

11.4 Canopus Bioscience

11.4.1 Canopus Bioscience Company Detail

11.4.2 Canopus Bioscience Business Overview

11.4.3 Canopus Bioscience Circulating Tumor Cells (CTC) Introduction

11.4.4 Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)

11.4.5 Canopus Bioscience Recent Development

11.5 Creatv Microtech

11.5.1 Creatv Microtech Company Detail

11.5.2 Creatv Microtech Business Overview

11.5.3 Creatv Microtech Circulating Tumor Cells (CTC) Introduction

11.5.4 Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)

11.5.5 Creatv Microtech Recent Development

11.6 Ikonisys

11.6.1 Ikonisys Company Detail

11.6.2 Ikonisys Business Overview

11.6.3 Ikonisys Circulating Tumor Cells (CTC) Introduction

11.6.4 Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)

11.6.5 Ikonisys Recent Development

11.7 IV Diagnostics

11.7.1 IV Diagnostics Company Detail

11.7.2 IV Diagnostics Business Overview

11.7.3 IV Diagnostics Circulating Tumor Cells (CTC) Introduction

11.7.4 IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)

11.7.5 IV Diagnostics Recent Development

11.8 Miltenyi Biotech

11.8.1 Miltenyi Biotech Company Detail

11.8.2 Miltenyi Biotech Business Overview

11.8.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Introduction

11.8.4 Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)

11.8.5 Miltenyi Biotech Recent Development

11.9 Nanostring Technologies

11.9.1 Nanostring Technologies Company Detail

11.9.2 Nanostring Technologies Business Overview

11.9.3 Nanostring Technologies Circulating Tumor Cells (CTC) Introduction

11.9.4 Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)

11.9.5 Nanostring Technologies Recent Development

11.10 Rarecells Diagnostics

11.10.1 Rarecells Diagnostics Company Detail

11.10.2 Rarecells Diagnostics Business Overview

11.10.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Introduction

11.10.4 Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)

11.10.5 Rarecells Diagnostics Recent Development

11.11 Vitatex

11.11.1 Vitatex Company Detail

11.11.2 Vitatex Business Overview

11.11.3 Vitatex Circulating Tumor Cells (CTC) Introduction

11.11.4 Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)

11.11.5 Vitatex Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Nanostring Technologies

Rarecells Diagnostics

Vitatex Inc

List of Tables

Table 1. Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Ex-Vivo Positive Selection

Table 3. Key Players of In-Vivo Positive Selection

Table 4. Key Players of Negative Selection

Table 5. Key Players of Microchips & Single Spiral Micro Channel

Table 6. Global Circulating Tumor Cells (CTC) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Circulating Tumor Cells (CTC) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Circulating Tumor Cells (CTC) Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Circulating Tumor Cells (CTC) Market Share by Region (2019-2024)

Table 10. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Circulating Tumor Cells (CTC) Market Share by Region (2025-2030)

Table 12. Circulating Tumor Cells (CTC) Market Trends

Table 13. Circulating Tumor Cells (CTC) Market Drivers

Table 14. Circulating Tumor Cells (CTC) Market Challenges

Table 15. Circulating Tumor Cells (CTC) Market Restraints

Table 16. Global Circulating Tumor Cells (CTC) Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Circulating Tumor Cells (CTC) Market Share by Players (2019-2024)

Table 18. Global Top Circulating Tumor Cells (CTC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) as of 2023)

Table 19. Ranking of Global Top Circulating Tumor Cells (CTC) Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Circulating Tumor Cells (CTC) Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Circulating Tumor Cells (CTC) Product Solution and Service

Table 23. Date of Enter into Circulating Tumor Cells (CTC) Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Circulating Tumor Cells (CTC) Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2019-2024)

Table 27. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2025-2030)

Table 29. Global Circulating Tumor Cells (CTC) Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2019-2024)

Table 31. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2025-2030)

Table 33. North America Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Circulating Tumor Cells (CTC) Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Circulating Tumor Cells (CTC) Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Circulating Tumor Cells (CTC) Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Circulating Tumor Cells (CTC) Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Circulating Tumor Cells (CTC) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2025-2030) & (US$ Million)

Table 48. AdnaGen Company Detail

Table 49. AdnaGen Business Overview

Table 50. AdnaGen Circulating Tumor Cells (CTC) Product

Table 51. AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2019-2024) & (US$ Million)

Table 52. AdnaGen Recent Development

Table 53. Apocell Company Detail

Table 54. Apocell Business Overview

Table 55. Apocell Circulating Tumor Cells (CTC) Product

Table 56. Apocell Revenue in Circulating Tumor Cells (CTC) Business (2019-2024) & (US$ Million)

Table 57. Apocell Recent Development

Table 58. Biocep Company Detail

Table 59. Biocep Business Overview

Table 60. Biocep Circulating Tumor Cells (CTC) Product

Table 61. Biocep Revenue in Circulating Tumor Cells (CTC) Business (2019-2024) & (US$ Million)

Table 62. Biocep Recent Development

Table 63. Canopus Bioscience Company Detail

Table 64. Canopus Bioscience Business Overview

Table 65. Canopus Bioscience Circulating Tumor Cells (CTC) Product

Table 66. Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2019-2024) & (US$ Million)

Table 67. Canopus Bioscience Recent Development

Table 68. Creatv Microtech Company Detail

Table 69. Creatv Microtech Business Overview

Table 70. Creatv Microtech Circulating Tumor Cells (CTC) Product

Table 71. Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2019-2024) & (US$ Million)

Table 72. Creatv Microtech Recent Development

Table 73. Ikonisys Company Detail

Table 74. Ikonisys Business Overview

Table 75. Ikonisys Circulating Tumor Cells (CTC) Product

Table 76. Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2019-2024) & (US$ Million)

Table 77. Ikonisys Recent Development

Table 78. IV Diagnostics Company Detail

Table 79. IV Diagnostics Business Overview

Table 80. IV Diagnostics Circulating Tumor Cells (CTC) Product

Table 81. IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2019-2024) & (US$ Million)

Table 82. IV Diagnostics Recent Development

Table 83. Miltenyi Biotech Company Detail

Table 84. Miltenyi Biotech Business Overview

Table 85. Miltenyi Biotech Circulating Tumor Cells (CTC) Product

Table 86. Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2019-2024) & (US$ Million)

Table 87. Miltenyi Biotech Recent Development

Table 88. Nanostring Technologies Company Detail

Table 89. Nanostring Technologies Business Overview

Table 90. Nanostring Technologies Circulating Tumor Cells (CTC) Product

Table 91. Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2019-2024) & (US$ Million)

Table 92. Nanostring Technologies Recent Development

Table 93. Rarecells Diagnostics Company Detail

Table 94. Rarecells Diagnostics Business Overview

Table 95. Rarecells Diagnostics Circulating Tumor Cells (CTC) Product

Table 96. Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2019-2024) & (US$ Million)

Table 97. Rarecells Diagnostics Recent Development

Table 98. Vitatex Company Detail

Table 99. Vitatex Business Overview

Table 100. Vitatex Circulating Tumor Cells (CTC) Product

Table 101. Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2019-2024) & (US$ Million)

Table 102. Vitatex Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Circulating Tumor Cells (CTC) Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Circulating Tumor Cells (CTC) Market Share by Type: 2023 VS 2030

Figure 3. Ex-Vivo Positive Selection Features

Figure 4. In-Vivo Positive Selection Features

Figure 5. Negative Selection Features

Figure 6. Microchips & Single Spiral Micro Channel Features

Figure 7. Global Circulating Tumor Cells (CTC) Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Circulating Tumor Cells (CTC) Market Share by Application: 2023 VS 2030

Figure 9. Tumorigenesis Research Case Studies

Figure 10. Emt Biomarkers Development Case Studies

Figure 11. Cancer Stem Cell Research Case Studies

Figure 12. Others Case Studies

Figure 13. Circulating Tumor Cells (CTC) Report Years Considered

Figure 14. Global Circulating Tumor Cells (CTC) Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Circulating Tumor Cells (CTC) Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Circulating Tumor Cells (CTC) Market Share by Region: 2023 VS 2030

Figure 17. Global Circulating Tumor Cells (CTC) Market Share by Players in 2023

Figure 18. Global Top Circulating Tumor Cells (CTC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Circulating Tumor Cells (CTC) Revenue in 2023

Figure 20. North America Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Circulating Tumor Cells (CTC) Market Share by Country (2019-2030)

Figure 22. United States Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Circulating Tumor Cells (CTC) Market Share by Country (2019-2030)

Figure 26. Germany Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Circulating Tumor Cells (CTC) Market Share by Region (2019-2030)

Figure 34. China Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Circulating Tumor Cells (CTC) Market Share by Country (2019-2030)

Figure 42. Mexico Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Circulating Tumor Cells (CTC) Market Share by Country (2019-2030)

Figure 46. Turkey Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Circulating Tumor Cells (CTC) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. AdnaGen Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2019-2024)

Figure 49. Apocell Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2019-2024)

Figure 50. Biocep Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2019-2024)

Figure 51. Canopus Bioscience Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2019-2024)

Figure 52. Creatv Microtech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2019-2024)

Figure 53. Ikonisys Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2019-2024)

Figure 54. IV Diagnostics Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2019-2024)

Figure 55. Miltenyi Biotech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2019-2024)

Figure 56. Nanostring Technologies Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2019-2024)

Figure 57. Rarecells Diagnostics Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2019-2024)

Figure 58. Vitatex Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Color Detection Sensors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G9623

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Appendix Cancer Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2H1312

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions